RT Journal Article
SR Electronic
T1 A systematic review and modelling insights of factors impacting measles vaccine effectiveness
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.29.24312705
DO 10.1101/2024.08.29.24312705
A1 Ghosh, Samiran
A1 Kappara, Divya
A1 Majumder, Nabanita
A1 Nath-Sain, Suchita
A1 Mukhopadhyay, Siuli
YR 2024
UL http://medrxiv.org/content/early/2024/08/29/2024.08.29.24312705.abstract
AB Background & objectives Outbreaks of measles have been frequently reported despite the availability of an effective vaccine. In this systematic review we examine the potential factors that could impact the effectiveness of the measles vaccine (MV) in children.Methods We conducted a literature search using PubMed and Google Scholar for primary articles published between 2014 and July 2024. Articles reporting the effectiveness or immunogenicity of MV in children aged 0-15 years were included. Additionally, we use regression analysis on data available from few cohort studies in India and epidemiological modelling simulations to assess the effect of factors on vaccine effectiveness (VE).Results Overall, 34 primary articles involving 151888 children who had received the MV were included in the analysis. Key factors that may affect VE were malnutrition, genetic variants, chemotherapy and gender. Through modelling we identified an inverse relationship between malnutrition and measles VE and estimated the possible percentage decrease in VE due to malnutrition across different states of India. Additionally, simulations from a Susceptible-Infected type model showed the effect of varying VE on the modelling outcomes and measles elimination targets.Interpretation & conclusions We identified a few key factors that impact measles VE. Therefore, in addition to maintaining WHO recommended vaccine coverages, addressing the problems related to VE is crucial for achieving measles elimination targets.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this study was provided by the Bill & Melinda Gates Foundation (INV-044445).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used data from published works and they are properly cited in the paper.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are taken from published research works and are contained in the manuscript.